They have received the results from the 3rd party, there are a number of staff with degrees in their field who should be able to have this data ready to present to investors before the CR. I think the "missed projections" argument has been and gone, it's now in their hands, if the results are good there is no reason for them not to release a well put together press release saying here are our findings from the phase 2 human trials, now let us raise credit to the tune of 30,000,000 diluting shares and options rather than 70,000,000 because we know how to run a business.
- Forums
- ASX - By Stock
- BIT
- CR before results=poor results?
CR before results=poor results?, page-7
-
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIT (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.2¢ |
Change
0.001(4.76%) |
Mkt cap ! $19.85M |
Open | High | Low | Value | Volume |
2.1¢ | 2.2¢ | 1.9¢ | $16.14K | 809.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 66 | 1.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.2¢ | 1031102 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 66 | 0.019 |
6 | 506555 | 0.018 |
11 | 1185872 | 0.017 |
10 | 3659154 | 0.016 |
10 | 1266688 | 0.015 |
Price($) | Vol. | No. |
---|---|---|
0.022 | 1031102 | 3 |
0.023 | 1449422 | 4 |
0.024 | 612849 | 2 |
0.025 | 223000 | 3 |
0.027 | 7508 | 1 |
Last trade - 16.10pm 24/09/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online